WASHINGTON—AbbVie Inc. agreed to divest itself of several pharmaceutical assets to settle the Federal Trade Commission’s antitrust objections to its proposed $63 billion acquisition of Botox maker Allergan PLC.

The FTC voted 3-2 along party lines Tuesday to approve the proposed settlement.

The companies said in a statement that the settlement…

Read More